Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): A randomised controlled trial

被引：0
|
作者：
Estes, N. A. Mark, III [1 ]
机构：
[1] Tufts Univ, Sch Med, New England Cardiac Arrhythmia Ctr, Div Cardiol,Dept Med, Boston, MA 02111 USA
来源：
HEART RHYTHM | 2008年 / 5卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：166 / 166
页数：1
相关论文
共 50 条
  • [41] Optimal warfarin anticoagulation and the prevention of stroke in patients with atrial fibrillation: a population-based study
    Azoulay, L.
    Simon, T.
    Dell'aniello, S.
    Renoux, C.
    Suissa, S.
    EUROPEAN HEART JOURNAL, 2010, 31 : 155 - 155
  • [42] The DESPATCH study: Delivering stroke prevention for patients with atrial fibrillation - a cluster randomised controlled trial in primary healthcare
    Gattellari, Melina
    Oldmeadow, Christopher
    Pelazzi, Kerrin
    Leung, Dominic
    Zwar, Nicholas
    Worthington, John
    INTERNATIONAL JOURNAL OF STROKE, 2018, 13 : 27 - 27
  • [43] Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial
    Hobbs, F. D. R.
    Roalfe, A. K.
    Lip, G. Y. H.
    Fletcher, K.
    Fitzmaurice, D. A.
    Mant, J.
    BMJ-BRITISH MEDICAL JOURNAL, 2011, 342
  • [44] A cross-sectional study of quality of life in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation Treatment of the Aged study
    Roalfe, Andrea K.
    Bryant, Toni L.
    Davies, Matthew H.
    Hackett, Thomas G.
    Saba, Samiramis
    Fletcher, Kate
    Lip, Gregory Y. H.
    Hobbs, F. D. Richard
    Mant, Jonathan
    EUROPACE, 2012, 14 (10): : 1420 - 1427
  • [45] PLACEBO-CONTROLLED, RANDOMIZED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL-FIBRILLATION
    PETERSEN, P
    BOYSEN, G
    GODTFREDSEN, J
    ANDERSEN, ED
    ANDERSEN, B
    LANCET, 1989, 1 (8631): : 175 - 179
  • [46] Improving outcomes in patients with atrial fibrillation: Rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial
    Kirchhof, Paulus
    Breithardt, Guenter
    Camm, A. John
    Crijns, Harry J.
    Kuck, Karl-Heinz
    Vardas, Panos
    Wegscheider, Karl
    AMERICAN HEART JOURNAL, 2013, 166 (03) : 442 - 448
  • [47] Randomised controlled trial of population screening for atrial fibrillation in people aged 70 years and over to reduce stroke: protocol for the SAFER trial
    Mant, Jonathan
    Modi, Rakesh N.
    Dymond, Andrew
    Armstrong, Natalie
    Burt, Jenni
    Calvert, Peter
    Cowie, Martin
    Ding, Wern Yew
    Edwards, Duncan
    Freedman, Ben
    Griffin, Simon J.
    Hoare, Sarah
    Hobbs, F. D. Richard
    Johnson, Rachel
    Kaptoge, Stephen
    Lip, Gregory Y. H.
    Lobban, Trudie
    Lown, Mark
    Lund, Jenny
    McManus, Richard J.
    Mills, Mark T.
    Morris, Stephen
    Powell, Alison
    Proietti, Riccardo
    Sutton, Stephen
    Sweeting, Mike
    Thom, Howard
    Williams, Kate
    BMJ OPEN, 2024, 14 (04):
  • [48] Clopidogrel and aspirin in patients with atrial fibrillation - ACTIVE A study (Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events)
    Moser, M.
    Bode, C.
    Nitschmann, S.
    INTERNIST, 2010, 51 (01): : 100 - 102
  • [49] The impact of age on the effectiveness and safety of the NOACs versus warfarin for stroke prevention in atrial fibrillation
    Noseworthy, P.
    Yao, X.
    Shah, N. D.
    EUROPEAN HEART JOURNAL, 2017, 38 : 839 - 840
  • [50] Effect of warfarin versus aspirin on stroke incidence in atrial fibrillation with normal and abnormal ejection fraction
    Aronow, W
    Kronzon, I
    Gutstein, H
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2000, 48 (08) : S21 - S21
12345